Suppliers / Shandong Boyuan Pharmaceutical

Shandong Boyuan Pharmaceutical

China 8 employees Updated 9 July 2026

Shandong Boyuan Pharmaceutical is an API manufacturer based in China. It holds 5 valid CEPs across a filed portfolio of 5 molecules.

0
active US DMFs
5
valid CEPs
2
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Jinan, China Not on file
Jinan City, China Not on file

What they file, and where

Questions about Shandong Boyuan Pharmaceutical

Does Shandong Boyuan Pharmaceutical hold a US DMF or a CEP?
Shandong Boyuan Pharmaceutical holds 5 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Shandong Boyuan Pharmaceutical manufacture?
2 registered sites are on record, in China (Jinan and Jinan City). Every site is listed on this page with the register it came from.
What does Shandong Boyuan Pharmaceutical make?
5 molecules are on record against Shandong Boyuan Pharmaceutical, including Capecitabine, Oxaliplatin, Pemetrexed Disodium and Racecadotril. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Shandong Boyuan Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability